Request Demo
Last update 02 Dec 2025
Full-Life Technologies GmbH
Private Company|2023|Germany
Private Company|2023|Germany
Last update 02 Dec 2025
Overview
Tags
Neoplasms
Urogenital Diseases
Radionuclide Drug Conjugates (RDC)
Therapeutic radiopharmaceuticals
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT06492122
A Phase 1, First-in-Human, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of [225Ac]Ac-FL-020 in Participants With mCRPC.
CTR20254762
一项在转移性去势抵抗性前列腺癌（mCRPC）受试者中评价[225Ac]Ac-FL-020注射液（一种抗PSMA放射性核素偶联药物[RDC]）的安全性、耐受性和抗肿瘤活性的首次人体、I期剂量递增和扩展研究
[Translation] A first-in-human, phase I dose-escalation and expansion study evaluating the safety, tolerability, and antitumor activity of [225Ac]Ac-FL-020 injection (an anti-PSMA radionuclide conjugate [RDC]) in patients with metastatic castration-resistant prostate cancer (mCRPC).
100 Clinical Results associated with Full-Life Technologies GmbH
Login to view more data
Login to view more data
100 Deals associated with Full-Life Technologies GmbH
Login to view more data
100 Translational Medicine associated with Full-Life Technologies GmbH
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 20 Dec 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free